TrialDiabetes care2022

Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study.

Haiyan Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.